Sonoma Pharmaceuticals, Inc. Common Stock
$1.28
Market Cap
$6.03M
Shares Outstanding
4.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 25, 2007
Round Lot
100
Locale
US
Day Open
$1.26
Day High
$1.34
Day Low
$1.24
Volume
147.6K
VWAP
$1.29
Prev Close
$1.26
Transactions
--
Acc. Volume
--
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) closed the 2026-09-18 session at $1.28, up 1.59% versus the previous close (+0.02). The stock opened at $1.26 and traded between $1.24 and $1.34 during that session. Session trading volume was 148K shares. The volume-weighted average price (VWAP) is $1.29.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Sonoma Pharmaceuticals, Inc. Common Stock has a market capitalization of $6.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. SNOA is listed on the XNAS exchange. The company employs approximately 260 people. Sonoma Pharmaceuticals, Inc. Common Stock is headquartered in BOULDER, CO. The recorded listing date is 2007-01-25.
On this page you can find market SNOA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.